Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromboembolic complications. Therefore, an adequate anti-thrombotic prophylaxis is recommended in hospitalized COVID-19 patients. Although rapidly worsening respiratory symptoms in a patient with SARS-CoV-2 respiratory infection may correlate with worsening pneumonia itself, it may also mask a pulmonary embolism. We report the case of a 50-year-old man affected by SARS-CoV-2 pneumonia, who developed acute pulmonary embolism.
CITATION STYLE
Lorenzo, C., Francesca, B., Francesco, P., Elena, C., Luca, S., & Paolo, S. (2020). Acute pulmonary embolism in COVID-19 related hypercoagulability. Journal of Thrombosis and Thrombolysis, 50(1), 223–226. https://doi.org/10.1007/s11239-020-02160-1
Mendeley helps you to discover research relevant for your work.